Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation

Nature Cell Biology

Volumn 1, Issue 1, 1999, Pages 14-19

  Marti, A ^a   Wirbelauer, C ^a   Scheffner, M ^b   Krek, W ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; E2F1 PROTEIN, MOUSE; LIGASE; RETINOBLASTOMA BINDING PROTEIN 1; S PHASE KINASE ASSOCIATED PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL LINE; CELL STRAIN 3T3; ENZYME SPECIFICITY; HELA CELL; HOMEOSTASIS; HUMAN; KINETICS; METABOLISM; MOUSE; PHYSIOLOGY;

3T3 CELLS; ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; G2 PHASE; HELA CELLS; HOMEOSTASIS; HUMANS; KINETICS; LIGASES; MICE; S PHASE; S-PHASE KINASE-ASSOCIATED PROTEINS; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 0033130137     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/8984     Document Type: Article

References (45)

1. King, R. W., Deshaies, R. J., Peters, J. & Kirschner, M. W. How proteolysis drives the cell cycle. Science 274, 1652-1659 (1996).
2. Wang, Z. M., Yang, H. & Livingston, D. M. Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts. Proc. Natl Acad. Sci. USA 95, 15583-15586 (1998).
3. Leone, G. et al. E2F-3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12, 2120-2130 (1998).
4. Campanero, M. R. & Flemington, E. K. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl Acad. Sci. USA 94, 2221-2226 (1997).
5. Hofmann, F., Martelli, F., Livingston, D. M. & Wang, Z. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev. 10, 2949-2959 (1996).
6. Hateboer, G., Kerkhoven, R. M., Shvarts, A., Bernards, R. & Beijersbergen, R. L. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10, 2960-2970 (1996).
7. Johnson, D. G., Ohtani, K. & Nevins, J. R. Oncogenic capacity of the E2F-1 gene. Proc. Natl Acad. Sci. USA 91, 12823-12827 (1994).
8. Singh, P., Wong, S. & Hong, W. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13, 3329-3338 (1994).
9. Xu, G., Livingston, D. M. & Krek, W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl Acad. Sci. USA 92, 1357-1361 (1995).
10. Johnson, D. G., Schwarz, J. K., Cress, W. D. & Nevins, J. R. Expression of transcription factor E2F-1 induced quiescent cells to enter S phase. Nature 365, 349-352 (1993).
11. Kowalik, T. F., DeGregori, J., Schwarz, J. K. & Nevins, J. R. E2F-1 overexpression in quiescent fibroblasts leads to induction of DNA synthesis and apoptosis. J. Virol. 69, 2491-2500 (1995).
12. Qin, X.-Q., Livingston, D. M., Kaelin, W. G. & Adams, P. Deregulated transcription factor E2F-1 expression leads to S phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA 91, 10918-10922 (1994).
13. Shan, B. & Lee, W.-H. Deregulated expression of E2F-1 induces S phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173 (1994).
14. Wu, X. & Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl Acad. Sci. USA 91, 3602-3606 (1994).
15. Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548 (1996).
16. Field, J. S. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561 (1996).
17. Hochstrasser, M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30, 405-439 (1996).
18. Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-274 (1996).
19. Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p/ cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221-230 (1997).
20. Patton, E. E. et al. Cdc53 is a scaffold protein for multiple Cdc34/Skp 1/F-box protein complexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev. 12, 692-705 (1998).
21. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209-219 (1997).
22. Elledge, S. J. & Harper, J. W. The role of proteolysis in the cell cycle and cancer. Biochim. Biophys. Acta 17, 61-70 (1998).
23. Patton, E. E., Willems, A. R. & Tyers, M. Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet. 14, 236-243 (1998).
24. Krek, W. Proteolysis and the G1-S transition: the SCF connection. Curr. Opin. Genet. Dev. 8, 36-42 (1998).
25. Mathias, N. et al. Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins. Mol. Cell. Biol. 16, 6634-6643 (1996).
26. Willems, A. R. et al. Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell 86, 453-163 (1996).
27. Zhang, H., Kobayashi, R., Galaktionov, K. & Beach, D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82, 915-925 (1995).
28. Lisztwan, J. et al. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17, 368-383 (1998).
29. Lyapina, S. A., Correll, C. C., Kipreos, E. T. & Deshaies, R. J. Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein. Proc. Natl Acad. Sci. USA 95, 7451-7456 (1998).
30. Yu, Z. K., Gervais, J. L. M. & Zhang, H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/AVAF1) and cyclin D proteins. Proc. Natl Acad. Sci. USA 95, 11324-11329 (1998).
31. Michel, J. J. & Xiong, Y. Human Cul-1, but not other cullin family members selectively interacts with SKP1 to from a complex with SKP2 and cyclin A. Cell Growth Differ. 9, 435-449 (1998).
32. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998).
33. Krek, W. et al. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161-172 (1994).
34. Dynlacht, B. D., Flores, O., Lees, J. A. & Harlow, E. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8, 1772-1786 (1994).
35. Xu, M., Sheppard, K. A., Peng, C. Y., Yee, A. S. & Piwnica-Worms, H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14, 8420-8431 (1994).
36. Zindy, F. et al. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182, 1144-1154 (1992).
37. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W. & Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 961-971 (1992).
38. Girard, F., Strausfeld, U., Fernandez, A. & Lamb, N. J. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 169-1179 (1991).
39. Krek, W., Xu, G. & Livingston, D. M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83, 1149-1158 (1995).
40. van den Heuval, S. & Harlow, E. Distinct roles for cydin-dependent kinases in cell cycle control. Science 262, 2050-2054 (1993).
41. Treier, M., Staszewski, L. M. & Bohmann, D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 78, 787-798 (1994).
42. Morgenstern, J. P. & Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug resistance markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596 (1990).
43. Krek, W., Livingston, D. M. & Shirodkar, S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262, 1557-1560 (1993).
44. Banerjee, A., Gregori, L., Xu, Y. & Chau, V. The bacterially expressed yeast CDC34 gene product can undergo autoubiquitination to form a multiubiquitin chain-linked protein. J. Biol. Chem. 268, 5668-5675 (1993).
45. Scheffner, M., Nuber, U. & Huibregtse, J. M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83 (1995).